Holding(s) in Company

RNS metadata

Holding(s) in Company | RNS | Ticker

RNS Announcement

RNS Number : 3240Y

Advanced Medical Solutions Grp PLC

20 February 2013




TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESⁱ

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ⁱⁱ		Advanced Medical Solutions Group plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights			√
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: ⁱⁱⁱ	Aviva plc & its subsidiaries
4. Full name of shareholder(s) (if different from 3.):^iv	Registered Holder: BNY (Nominees) Limited 107,699* BNY Norwich Union Nominees Limited 1,184,854* Chase (GA Group) Nominees Limited 7,493,827* Chase Nominees Limited 205,800* Vidacos Nominees Limited 65,686* * denotes direct interest Vidacos Nominees Limited 1,389,516
5. Date of the transaction and date on which the threshold is crossed or reached: ^v	19 February 2013
6. Date on which issuer notified:	20 February 2013
7. Threshold(s) that is/are crossed or reached: ^{vi, vii}	<5% to 5% Change at Combined Interest Level

8. Notified details:
A: Voting rights attached to shares ^{viii, ix}
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction				Resulting situation after the triggering transaction
	Number of Shares		Number of Voting Rights		Number of shares	Number of voting rights			% of voting rights ^x
					Direct	Direct ^xi		Indirect ^xii	Direct		Indirect
Ordinary Shares GB0004536594	8,707,866		8,707,866		10,447,382	9,057,866		1,389,516	4.43%		0.68%


B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Expiration date ^xiii		Exercise/ Conversion Period ^xiv			Number of voting rights that may be acquired if the instrument is exercised/ converted.			% of voting rights

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: ^xxi

The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-

Aviva Investors Global Services Limited:

· Aviva plc (Parent Company)

· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

· Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

· Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

Proxy Voting:
10. Name of the proxy holder:		See Section 4
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:	Figures are based on a total number of voting rights of 204,633,339 as per the Company's Total Voting Rights Announcement of 31 January 2013.
14. Contact name:	Neil Whittaker, Aviva plc
15. Contact telephone number:	01603 684420

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLURSSROBAUUAR

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ^{xv, xvi}

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date ^xvii

Exercise/
Conversion period ^xviii

Number of voting rights instrument refers to

% of voting rights ^{xix, xx}